This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners (NPs), physician assistants (PAs), and other healthcare professionals involved in the care of patients with Congenital Sucrase-Isomaltase Deficiency (CSID).
The series will focus on emerging treatment updates and review current treatment guidelines.
Upon completion of this educational activity, participants should be able to:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and the Gi Health Foundation (GIHF). RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.
RMCHCS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All faculty, staff, and reviewers involved in the planning, review, or presentation of continuing education activities sponsored/provided by Rehoboth McKinley Christian Health Care Services (RMCHCS) are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material
Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. All additional planning committee members, staff, and reviewers of the Gi Health Foundation (GIHF) and Rehoboth McKinley Christian Health Care Services (RMCHCS) have no relationships to disclose.
Americans with Disabilities Act:
The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-888-565-5321.
This program is supported by an educational grant from QOL Medical, LLC.